cells, osteoblasts, keratinocytes and augments Ha-ras-induced transformation of NIH 3T3 cells. [12] [13] [14] [15] Despite the important role of C/EBPb in growth stimulation, the mechanism underlying MCE is not fully understood.
The methylation of lysine residues in histones is a central epigenetic modification in the regulation of eukaryotic gene expression. While methylation at H3K4 and H3K36 primarily transduces activating signals, methylation at H3K9, H3K27, and H4K20 is associated primarily with repressed chromatin. Kdm4b is a Jmjc-domain containing histone demethylase for H3K9me3. Recent studies have shown that Kdm4b is required for estrogen receptor a (ERa)-regulated breast cancer progression and mammary epithelial cells (MECs) proliferation. [16] [17] [18] In the present study, Kdm4b was identified as a target gene of C/EBPb that functions as a co-factor of C/EBPb to demethylate H3K9me3 in the regulatory regions of C/EBPb-regulated cell cycle genes Cdc45l (cell division cycle 45 homolog), Mcm3 (mini-chromosome maintenance complex component 3), Gins1 (GINS complex subunit 1) and Cdc25c (cell division cycle 25 homolog c), thereby promoting their expression and MCE. This explains why C/EBPb is required for MCE during adipocyte differentiation.
Results
Identification of C/EBPb binding sites during the MCE of 3T3-L1 preadipocyte differentiation. A promoter-wide chromatin immunoprecipitation (ChIP)-on-chip analysis was employed on 3T3-L1 cells harvested at 20 h after hormonal induction when the cells are in the middle S phase during the first round of MCE. 5, 19 Nine-hundred and forty-one significant C/EBPb binding regions were identified (Supplementary  Table S1 ). To validate the ChIP-on-chip data, C/EBPb enrichment was measured by ChIP quantitative PCR (ChIP-qPCR) at 30 novel binding regions and 29 of these sites were positive (Supplementary Figure S1a) . Fifteen of these sites were also tested by ChIP-qPCR with another C/EBPb antibody and a similar result was obtained as with the original antibody used for the ChIP-on-chip assays (Supplementary Figure S1b) . Distribution analysis of the binding sites relative to the TSS showed that the majority of C/EBPb binding regions were located at distances within 2 kb from the nearest annotated transcription start sites (TSSs) (Figure 1a ). Further analysis revealed that B30% of C/EBPb binding sites were at proximal promoters ( Figure 1b , TSS to À 1 kb), and B30% of the sites fell within distal promoters, defined as 41 kb upstream from TSS ( Figure 1b , 41 kb), while many other sites (26.84%) were located in introns ( Figure 1b ). Evolutionary conservation of the C/EBPb binding regions was examined to show that there is a high degree of conservation of C/EBPb binding sites among higher eukaryotes (Figure 1c ), suggesting that these binding sites are likely to be functional transcriptional regulatory regions across species.
The sequences of C/EBPb-bound regions were mined to further identify potential binding motifs for transcription factors. A de novo motif search identified a sequence that strongly resembles the C/EBP recognition element as the topscoring motif (Figure 1d ). Consistently, the highest scoring motifs from the TRANSFAC database represented different matrices for C/EBP proteins (Figure 1e and Supplementary  Table S2 ). Gene expression microarrays were further Figure 1 Bioinformatic analyses of the ChIP-on-chip data. Post-confluent growth-arrested 3T3-L1 preadipocytes were induced to differentiation as described. At 20 h ChIP-on-chip were performed and analyzed. conducted for both control RNAi-treated cells and C/EBPb RNAi-treated cells to confirm the functional relationship between C/EBPb binding and gene transcription. Fourhundred and eighty-one genes were identified to be induced (20 h versus 0 h) in a C/EBPb-dependent manner (Supplementary Tables S3 and S4 ). When overlapping ChIP-on-chip data and microarray data, 68 potential C/EBPb target genes were identified (Figure 1f and Supplementary  Table S5 ).
Histone demethylase Kdm4b was identified as one of the C/EBPb target genes required for MCE during 3T3-L1 adipocyte differentiation. Lysine methylation on histones has a pivotal role in transcriptional regulation. 20 The histone demethylase Kdm4b (for H3K9me3) was among the 68 potential C/EBPb target genes identified above. This suggests that C/EBPb might regulate gene expression through indirect regulation of histone lysine methylation.
A DNA fragment containing the 5 0 -flanking region of Kdm4b gene was subcloned into the luciferase reporter construct pGL3-basic and transfected into 3T3-L1 preadipocytes with/out the C/EBPb expression plasmid. Luciferase activity was increased B10-fold when co-transfected with C/EBPb expression plasmid (Figure 2a) . Consistently, deletion of the C/EBP binding site ( À 577 to À 564 bp) identified in our ChIP-on-chip analysis almost totally abolished this transactivation. ChIP-qPCR confirmed that the Kdm4b promoter fragment containing the region of À 577 bpB À 564 bp was significantly enriched by the C/EBPb antibody at 16 h and 20 h after adipogenic induction (Figure 2b ). The specific binding of C/EBPb to this region was also confirmed by Electrophoretic Mobility Shift Assay (EMSA) (Supplementary Figure S2) . Upon induction of differentiation, Kdm4b messenger RNA (mRNA) level was significantly induced and this upregulation was prevented when C/EBPb was knocked down by RNAi (Figure 2c ). Consistently, Kdm4b protein level also increased post-induction and was impaired in C/EBPb RNAi-treated cells (Figure 2d ). The knockdown efficiency of C/EBPb RNAi was also confirmed (Figures 2c and d) and its effect on MCE and terminal adipocyte differentiation is consistent with our previous report. 10 While the expression of Kdm4b is significantly induced and regulated by C/EBPb, this is not the case for other Kdm4 family genes (Figure 2e ).
To further confirm the role of C/EBPb in Kdm4b induction, C/EBPb was overexpressed in 3T3-L1 cells ( Figure 2f ). As expected, ectopic expression of C/EBPb promoted MCE as illustrated by increased EdU incorporation (an indicator of DNA synthesis, like BrdU incorporation) (Figure 2g ), as well as adipocyte differentiation, as indicated by increased accumulation of cytoplasmic triglyceride (Figure 2h ) and enhanced the expression of Kdm4b at both 0 h and 20 h after adipogenic induction (Figure 2i ). These results demonstrate that Kdm4b is a bona fide target of C/EBPb during MCE.
Kdm4b has been shown to regulate cell proliferation, including estrogen-induced breast cancer growth and MECs proliferation. 16, 17 Therefore, we hypothesized that Kdm4b might also be involved in regulating MCE during 3T3-L1 preadipocyte differentiation. RNAi oligonucleotide of Kdm4b was transfected into 3T3-L1 preadipocytes. The efficiency and specificity of Kdm4b knockdown were confirmed by western blotting (Figure 3a ) and RT-qPCR (Supplementary Figure S3) respectively. The RNAi effect on DNA synthesis was evaluated by using EdU labeling. As shown in Figure 3b , Kdm4b knockdown caused less EdU incorporation. Furthermore, flow cytometry analysis revealed that knockdown of Kdm4b resulted in a significant reduction in the cell population in S phase (from 34 to 19%) with a concomitant increase in the (Figure 3c ). These data suggest that Kdm4b may promote MCE by facilitating G1/S transition. Consistently, cell proliferation was significantly inhibited from 1 to 4 days after induction ( Figure 3d ). In addition, when the MCE was inhibited after Kdm4b was knocked down, the terminal differentiation of 3T3-L1 cells was also suppressed as indicated by Oil Red O staining (Figure 3e ), as well as the adipocyte marker gene expression ( Figure 3f ). Collectively, these results indicate that Kdm4b is required for MCE.
Rescue experiments were performed to further confirm the above observation. As 3T3-L1 preadipocytes are of mouse origin, human Kdm4b was ectopically expressed in Kdm4b RNAi-treated 3T3-L1 cells by retrovirus transduction. Western blotting analysis demonstrated that human Kdm4b gene is resistant to mouse Kdm4b RNAi knockdown and was expressed at a similar level of total Kdm4b as the parental control cells (Figure 3a ). Forced expression of human Kdm4b led to significant rescue of MCE (Figures 3b-d ) and terminal adipocyte differentiation (Figures 3e-f ). These data reinforce the idea that Kdm4b has an important role in MCE.
Transcriptional activation of cell cycle genes Cdc45l, Mcm3, Gins1 and Cdc25c by C/EBPb during MCE. Gene ontology (GO) analysis revealed that four cell cycle genes (Cdc45l, Mcm3, Gins1 and Cdc25c) were among the 68 potential C/EBPb target genes (Supplementary Table S5 ). The expression of Cdc45l, Mcm3, Gins1 and Cdc25c was determined by RT-qPCR and western blotting. After hormonal induction, both the mRNA ( Figure 4a ) and protein levels ( Figure 4b ) increased at 8 h. The upregulation of these cell cycle genes occurred subsequent to that of the C/EBPb gene, which peaked at 4 h after induction (Figures 4a and b) . When C/EBPb expression was knocked down, the induction The binding of C/EBPb to the promoters of the four cell cycle genes was then investigated. The promoter regions of the four genes identified in the C/EBPb ChIP-on-chip data and the C/EBPb consensus sequences are illustrated in Supplementary Figure S4 . ChIP-qPCR assays were performed using primers covering these C/EBPb consensus sequences of the four genes.
As Figure 5a shows, C/EBPb associates with the promoters of the four genes at 16 h and 20 h after induction. In contrast, C/EBPb occupancy was hardly detectable in quiescent cells before induction (i.e., at 0 h). EMSA was also performed using probes containing the C/EBPb consensus sequences and nuclear extracts from 3T3-L1 cells at 20 h after induction. As shown in Figure 5b , DNA-protein complexes were formed with these probes (lanes 1, 6, 11, 16 ). The C/EBPb containing DNA-protein complexes were verified by the completely supershift of the complexes using C/EBPb antibody (lanes 3, 8, 13, and 18) compared with that with control IgG (lanes 2, 7, 12, and 17). Moreover, the inhibition of complex formation by unlabeled competitor oligonucleotide, but not by self probes mutated in the C/EBP consensus sequence (Supplementary Figure S4) , verified specific binding (compare lanes 4, 9, 14, 19 with lanes 5, 10, 15, 20) . Furthermore, promoter-luciferase reporter analysis indicates that C/EBPb transactivates the promoters of the four cell cycle genes and that mutation of the C/EBPb binding sites significantly reduces expression (Figure 5c ).
The role of the four cell cycle genes in MCE was further examined. Knockdown of the four genes inhibits MCE (Supplementary Figure S5) . Additionally, ectopic expression of the four genes together significantly rescues the inhibitory effect of C/EBPb RNAi on MCE (Supplementary Figure S6) . Taken together, the RNAi and overexpression experiments demonstrate that Cdc45l, Mcm3, Gins1 and Cdc25c, which are transactivated by C/EBPb, have an important role in MCE.
Histone demethylase Kdm4b serves as a co-factor of C/EBPb during MCE. Recent studies have revealed that Kdm4b is a direct target gene of ERa, forms complex with ERa and facilitates ERa-regulated transcription. 16, 17 As indicated above, Kdm4b has been shown to be a target gene of C/EBPb ( Figure 2 ) and like C/EBPb, Kdm4b is also required for MCE (Figure 3) . Thus, we hypothesized that Kdm4 might act as a co-factor of C/EBPb to promote MCE.
ChIP assays were performed to determine whether Kdm4b interacts with the C/EBPb-targeted cell cycle gene loci. The results revealed that, similar to C/EBPb, Kdm4b is recruited to the promoter regions of the four cell cycle genes 20 h after, but not before, induction (Figure 6a ). Furthermore, re-ChIP analysis indicated that the promoters of the four genes, which are immunoprecipitated by C/EBPb antibody, are re-immunoprecipitated by Kdm4b antibody (Figure 6b ). The interaction between C/EBPb and Kdm4b was further confirmed in coimmunoprecipitation experiments. Immunoprecipitation of the nuclear extracts at 20 h post-induction with C/EBPb antibody pulls down Kdm4b (Figure 6c) , and Kdm4b antibody also immunoprecipitates C/EBPb (Figure 6d ). Collectively, these results verify that C/EBPb and Kdm4b form a complex that targets the promoters of the four cell cycle genes. Furthermore, luciferase assays demonstrate that Kdm4b enhances the ability of C/EBPb to activate the promoters of the four cell cycle genes (Figure 6e ), which indicates that Kdm4b functions as a positive transcriptional co-factor for C/EBPb to regulate the four cell cycle genes.
Kdm4b is a histone demethylase that reverses tri-methylation at H3K9. H3K9me3 is generally associated with gene silencing and is enriched in heterochromatin of inactive genes. It was found that H3K9me3 modification of the promoter regions of Cdc45l, Mcm3, Gins1 and Cdc25c is high at 0 h and significantly decreases by 20 h after induction (Figures 7a-d) . Consistently, the decrease in H3K9me3 associated with these promoters following adipogenic induction was only observed in control, but not in Kdm4b-depleted cells (Figure 7e ). As expected, knockdown of the expression of Kdm4b impaired the induction of the four cell cycle genes (Figure 7f ).
C/EBPb and Kdm4b specifically regulate MCE, but not normal 3T3-L1 preadipocyte proliferation. To determine whether the function of C/EBPb and Kdm4b is specific to MCE, the effects of knocking down C/EBPb and Kdm4b on the proliferation of normal 3T3-L1 preadipocyte were examined. Knockdown of C/EBPb or Kdm4b neither significantly altered the growth rate of pre-confluent 3T3-L1 cell, as assessed by cell number analysis, nor cell cycle phase (Figures 8a and b, respectively) . Furthermore, only weak binding of C/EBPb or Kdm4b on the promoters of the four cell cycle genes was detected in pre-confluent 3T3-L1 cells (Figures 8c and d, respectively) . Consistently, the expression of the four cell cycle genes was not affected when C/EBPb or Kdm4b was knocked down (Figure 8e ). These observations indicate that C/EBPb and Kdm4b has a specific role in MCE, but not in normal 3T3-L1 preadipocyte proliferation.
Discussion
C/EBPb is a basic leucine zipper transcription factor expressed in various cell types and has been characterized as a regulator of differentiation, such as the differentiation of adipocytes, the female reproductive system, mammary gland and bone. [21] [22] [23] While these studies have shed light on its role in differentiation, some other studies also show that C/EBPb functions in cell proliferation of some experimental and neoplastic models. The mechanistic insight into C/EBPb action in those types of cell proliferation, however, is limited.
Kdm4b was originally shown to antagonize H3K9me3 at pericentric heterochromatin in mammalian cells. 24 Recent reports reveal that Kdm4b also functions in regulating gene expression. In ER signaling, Kdm4b demethylates H3K9me3 in the regulatory regions of ER responsive genes, thereby releasing a transcriptional block and promoting breast cancer cell proliferation and mammary gland development. [16] [17] [18] Our findings have identified a specific role for Kdm4b in MCE during the proliferative phase of adipocyte differentiation. Kdm4b was found to be a bona fide target gene of C/EBPb during MCE. C/EBPb upregulates Kdm4b expression (Figure 2 ), which in turn demethylates H3K9me3 associated with C/EBPb-regulated cell cycle genes, thereby activating the expression of these genes ( Figure 7) . Specifically, C/EBPb drives the expression of the four cell cycle genes via two pathways, one through transcriptional activation and the other through an epigenetic pathway (Supplementary Figure S7) . C/EBPb requires Kdm4b to reverse H3K9me3 modification thereby enhancing its transcriptional activity. Moreover, Kdm4b requires C/EBPb to be transcriptionally induced. This finding provides new insights into potential roles of C/EBPb in epigenetic and transcriptional regulation during MCE of preadipocyte differentiation. Of interest, C/EBPb is also required for mammary gland development. Deletion of C/EBPb results in retarded proliferation of MECs and severe inhibition of lobuloalveolar development, 25 which is similar to the phenotype of conditional deletion of Kdm4b in mammary epithelium. 17 Our findings suggest a collaboration between C/EBPb and Kdm4b during mammary gland development.
In the current study, four cell cycle genes were identified as direct targets of C/EBPb during MCE. Mcm3 is a component of MCM2-7 (mini-chromosome maintenance proteins 2-7) complex while Gins1 is a subunit of GINS (go-ichi-ni-san) complex. 26, 27 Cdc45l, MCM2-7 and GINS form a large complex referred to as CMG, which is found at the sites of DNA unwinding during replication and contains an intrinsic helicase activity. 28 The CMG complex is involved in the regulation of eukaryotic chromosomal DNA replication and is required for the initiation and elongation steps, as well as the co-ordination of DNA replication. 29 Cdc25c is a phosphotyrosine phosphatase belonging to the Cdc25 phosphatase family. It directs dephosphorylation of cyclin B-bound Cdc2 and triggers entry into mitosis. 30 A study indicates that Cdc25c not only has a role in mitosis, but also contributes to S-phase entry. 31 Our results verify that the four cell cycle genes are downstream target genes of C/EBPb during MCE (Figures  4, 5; Supplementary Figure S5-S6) . Knockdown of the four genes impairs MCE, followed by the inhibition of terminal adipocyte differentiation (Supplementary Figure S5) . This observation lends additional credence to the idea that MCE is an early essential step in the adipocyte differentiation program of 3T3-L1 cells.
Propidium iodide (PI) staining and EdU labeling experiments indicate that the inhibition of MCE by the knockdown of Kdm4b and the four cell cycle genes is followed by a blockade of the G1/S transition (Figures 3b and c; Supplementary  Figure S5b -S5c). These findings are also consistent with the role of C/EBPb in MCE, as functional disruption of C/EBPb blocks G1/S transition followed by the inhibition of MCE. 5, 11 Histone acetyltransferase binding to ORC1 (HBO1) is known to positively regulate the initiation of DNA replication. 32 Knockdown of HBO1 impairs the ability of 3T3-L1 preadipocytes to differentiate into mature adipocytes by inhibiting DNA replication and MCE. 33 In addition, aphidicolin and roscovitine, which are S-phase inhibitors, block DNA synthesis, MCE and adipogenesis in the process of 3T3-L1 adipocyte differentiation. 5, 6 Therefore, our present results together with previous reports, suggest that the regulation of G1/S transition is a key step in MCE. This hypothesis supports the notion that DNA replication during MCE increases the accessibility of promoter or enhancer elements to factors required for transcription of genes involved in the initiation of differentiation. 34 As proposed in this study, Kdm4b serves as a co-factor for C/EBPb to regulate cell cycle genes. To get a global sense of the potential collaboration between C/EBPb and Kdm4b during MCE, promoter-wide search of Kdm4b binding sites was performed. This analysis identified 379 Kdm4b binding regions at 20 h after 3T3-L1 preadipocytes were induced to differentiation (Supplementary Table S6 ). By integrating the C/EBPb and Kdm4b ChIP-on-chip data, 101 regions, which correspond to 119 genes, were found to be co-occupied by C/EBPb and Kdm4b (Supplementary Figure S8 and Table S7 ). Furthermore, 30 genes of the 68 potential C/EBPb target genes were also targeted by Kdm4b, including the four cell cycle genes described in this study (Supplementary  Table S8 ). We have previously reported that histone H4, which is involved in chromatin assembly and is required for normal progression of S phase, is transactivated by C/EBPb during MCE. 10 Intriguingly, histone H4 is also targeted by Kdm4b, as illustrated in the ChIP-on-chip data (Supplementary Table S6 and Table S8 ). Consistently, our study verifies that Kdm4b positively regulates the expression of histone H4 through demethylation of H3K9me3 on its promoter (Supplementary Figure S9) . Thus, C/EBPb and Kdm4b co-regulate the expression of cell cycle genes, as well as chromatin assembly genes, such as histone H4, to efficiently promote MCE. Knockdown of C/EBPb or Kdm4b does not appear to impair pre-confluent 3T3-L1 preadipocytes proliferation (Figure 8 ). This suggests that C/EBPb and Kdm4b are not general regulators of cell proliferation, but have specific functions in certain types of cell proliferation including MCE. Unlike the strong promoter bindings during MCE, C/EBPb and Kdm4b bind weakly to the promoters of the four cell cycle genes in pre-confluent 3T3-L1 cells (Figures 8c and d) . It is possible that additional co-factors or specific post-translational modifications of C/EBPb, which might be absent in pre-confluent 3T3-L1 cells, are required for efficient binding of C/EBPb and Kdm4b to these promoters during MCE.
In conclusion, our data indicate that C/EBPb transactivates Kdm4b, which regulates the epigenetic signature in C/EBPb binding regions leading to the induction of cell cycle genes and chromatin assembly genes and thereby promoting MCE (Supplementary Figure S7) . It is conceivable that through upregulation of Kdm4b, C/EBPb and Kdm4b form a feed forward regulatory loop to facilitate MCE. This suggests a profound role for C/EBPb in the epigenetic control of MCE and offers new insights into the critical action of C/EBPb in the proliferation of certain specific cell types.
Materials and Methods
Cell culture, induction of differentiation. 3T3-L1 preadipocytes were propagated and maintained in DMEM containing 10% calf serum and HEK293T cells were cultured in DMEM supplemented with 10% fetal bovine serum (FBS). To induce differentiation, 2-day post-confluent 3T3-L1 preadipocytes (designated 0 day or 0 h) were fed DMEM containing 10% FBS, 1 mg/ml insulin, 1 mM dexamethasone, and 0.5 mM 3-isobutyl-1-methylxanthine (MIX) until day 2. Cells were then fed DMEM supplemented with 10% FBS and 1 mg/ml insulin for 2 days, after which they were fed every other day with DMEM containing 10% FBS. Adipocyte gene expression and acquisition of the adipocyte phenotype begins on day 3 and is maximal by day 8. Cell number was determined by hemocytometer.
Oil red O staining. Oil red O staining was conducted as described. 19 Cells were washed three times with PBS and then fixed for 10 min with 3.7% formaldehyde. Oil red O (0.5% in isopropanol) was diluted with water (3 : 2), filtered through a 0.45 mm filter, and incubated with the fixed cells for 1 h at room temperature. Cells were washed with water, and the stained fat droplets in the cells were visualized by light microscopy and photographed.
ChIP and Re-ChIP. Cells were fixed with 1% formaldehyde for 10 min at room temperature. Glycine was added to a final concentration of 0.125 M, and the incubation was continued for additional 5 min. Cells were then washed twice with ice-cold PBS, harvested by scraping, pelleted, and resuspended in 1 ml SDS lysis buffer containing 50 mM Tris-HCl pH 8.0, 1% SDS, 10 mM EDTA, and protease inhibitors. Samples were sonicated eight times for 30 s each with an interval of 30 s with a Bioruptor sonicator (Diagenode, Liège, Belgium). Samples were centrifuged at 14 000 Â g at 4 1C for 10 min. After removal of an input aliquot (whole-cell extract), supernates were diluted 10-fold in ChIP dilution buffer containing 20 mM Tris-HCl pH 8.0, 150 mM NaCl, 2 mM EDTA, 1% TritonX-100, and complete protease inhibitor tablets. Samples were immunoprecipitated using antibodies against C/EBPb (sc-150 and sc-7962, Santa Cruz Biotechnologies, Santa Cruz, CA, USA), Kdm4b (A301-477A, Bethyl, Montgomery, AL, USA), H3K9me3 (ab8898, Abcam, Cambridge, MA, USA) or the non-specific IgG control (Abcam). Immunoprecipitated samples were eluted and reverse cross-linked by incubation overnight at 65 1C. Genomic DNA was then extracted using a PCR purification kit (Qiagen, Valencia, CA, USA). Primers for ChIP-qPCR were in the Supplementary Table S9 . ChIP data were normalized to control IgG or expressed as percentage of input. Re-ChIPs were done essentially the same as primary ChIPs. Beads from the first ChIP were incubated with 10 mM DTT at 37 1C for 30 min and the eluted immunocomplex were diluted 1 : 50 in dilution buffer followed by re-immunoprecipitation with the second antibodies.
ChIP-on-chip arrays and data analysis. ChIP-on-chip analysis was performed as described. 35 C/EBPb antibody (sc-150, Santa Cruz Biotechnologies) and Kdm4b antibody (A301-477A, Bethyl) were used for the ChIPs. ChIP samples were then amplified by ligation-mediated PCR, labeled and hybridized to Affymetrix mouse promoter 1.0 oligonucleotide tiling arrays (Affymetrix, Santa Clara, CA, USA, for C/EBPb) or Nimblegen mouse 385 K RefSeq promoter arrays (Roche NimbleGen, Madison, WI, USA, for Kdm4b). ChIP-on-chip assays were analyzed with MAT, with probes remapped to the February 2006 Mouse Genome Assembly (mm8). The threshold cutoffs for binding regions were FDRr1%. For each binding region, the nearest gene was determined, and the distance from the center of the binding region to the TSSs of the gene was calculated using CEAS 35, 36 according to gene coordinates in the February 2006 Mouse Genome Assembly (mm8). For conservation analysis, the ChIP regions were aligned at the center and uniformly expanded to 1500 bp at each end, and at each position the average phastCons score retrieved from UCSC Genome Browser (http:// genome.ucsc.edu) was generated for the average conservation plot.
Analysis of the enriched motifs. An enumeration-based de novo motif discovery method was performed on the ChIP-on-chip data. 37 Z-score was used to assess the significance of motif enrichment. Z À score ¼ (C À E)/sqrt (E), quantifying the significance of enrichment. Here, C and E represent the observed and expected numbers of instances in ChIP regions, respectively. Background regions were randomly selected from design regions of Affymetrix mouse Promoter array. Enrichment of known transcription factor motifs in the TRANSFAC database was evaluated by Z-scores. Using a matrix similarity threshold of 0.8, the numbers of instances in ChIP and background regions were counted for 554 annotated vertebrate PWMs.
GO analysis. GO analysis was performed using DAVID (http://david.abcc. ncifcrf.gov), by examining the biological processes in which these genes are involved, and using RefSeq mRNA IDs with the entire mouse genome as a background model. 35, 38 P-values were calculated using Fisher Exact statistics.
RNA interference. Synthetic RNAi oligonucleotides specific for regions in the C/EBPb, Kdm4b, Cdc45l, Mcm3, Gins1, Cdc25c mRNAs were designed and synthesized by Invitrogen (Carlsbad, CA, USA) Stealth RNAi. The silencing effects of several RNAi oligonucleotides were screened and tested initially for their ability to knock down the expression of these genes by RT-qPCR. The sequences for successful RNAi knockdown were listed in the Supplementary Table S10 . Stealth RNAi Negative Control Duplexes with a similar GC content were used as a negative control. 3T3-L1 cells were transfected at B50% confluence with RNAi oligonucleotides using Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer's instructions.
RNA isolation, qPCR analysis, and gene expression profiling. Total RNAs were extracted using Trizol (Invitrogen). First-strand cDNAs were synthesized using the PrimeScript reverse transcriptase and Random primers (Takara Bio, Otsu, Japan). qPCR was performed using primers as described. Power SYBR Green PCR Mastermix (Applied Biosystems, Carlsbad, CA, USA) and the PRISM 7300 instrument (Applied Biosystems) were used. Analysis was performed using the standard curve method and normalization of all genes of interest to the control gene 18S rRNA. Primers for RT-qPCR were available in the Supplementary  Table S9 . RT-qPCR data were normalized to 0 h time point of control RNAi-treated cells. Gene expression profiling was carried out by KangChen Bio-tech (Shanghai, China). At 0 h or 20 h after induction, total RNA from 3T3-L1 cells was extracted, amplified, labeled and hybridized using the NimbleGen system (Roche NimbleGen).
Western blotting. Cells were lysed with lysis buffer containing 2% SDS, 10 mM dithiothreitol, 50 mM Tris-HCl, pH 6.8, 10% glycerol, 0.002% bromphenol blue, 1 Â protease inhibitor mixture. Equal amounts of protein were separated by SDS-PAGE, and transferred to PVDF membrane (Millipore, Billerica, MA, USA), immunoblotted with antibodies. Antibodies recognizing the following proteins were used: PPARg (Santa Cruz Biotechnologies), C/EBPa (Santa Cruz Biotechnologies), 422/ap2 (prepared in Dr. Lane's lab), Cdc45l (GeneTex, Irvine, CA, USA), Mcm3 (GeneTex), Gins1 (Abgent, San Diego, CA, USA), Cdc25c (Santa Cruz Biotechnologies), C/EBPb (sc-150, Santa Cruz Biotechnologies), Kdm4b (A301-478A, Bethyl) and Hsp90 (Abcam).
EdU labeling, microscopic fluorescence, PI staining, and flow cytometry analysis. EdU labeling was performed as previously described. 39 Cells were induced to differentiation with standard protocol. Sixteen hours after induction, cells were labeled for 2 h with 10 mM EdU before fixation with 4% paraformaldehyde. EdU was stained by incubating for 20 min with 100 mM Tris (from 2 M stock, pH 8.5), 0.5 mM CuSO 4 , 10 mM fluorescent azide (from 100 mM stocks in DMSO), and 50 mM ascorbic acid (added last to the mix from a 0.5 M stock in water). The staining mix was prepared fresh each time and used for staining cells immediately after addition of ascorbate. Cells were then washed and counterstained with Hoechst. The incorporation of EdU was visualized by fluorescence microscopy. At each step described above, the cells were washed with PBS three times after treatment. For FACS analysis, EdU-labeled cells were trypsinized, treated with EdU-staining chemicals, washed and subjected to flow cytometry with FACScan (Becton Dickinson, Franklin Lakes, NJ, USA). For PI staining, cells were trypsinized, fixed with 2% (wt/vol) paraformaldehyde in 1 Â PBS. Then they were treated with 0.5 mg/ml RNase A for 1 h at room temperature and incubated with 0.1 mg/ml PI (Sigma, St. Louis, MO, USA) for 45 min at 37 1C. DNA content was determined by flow cytometry analysis.
Electrophoretic Mobility Shift Assay. Nuclei were isolated and nuclear extracts prepared using the buffer containing 0.3 M NaCl, 1 M urea, 1% Nonidet P-40, 25 mM HEPES (pH 7.9), and 1 mM DTT. Protein concentration was determined by the Bradford method (Bio-Rad, Hercules, CA, USA). EMSA was performed as follows. Reaction mixtures containing B0.25 ng of
